Your browser doesn't support javascript.
loading
Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puawaitanga o Nga Tapuwae Kia Ora Tonu).
Connolly, Martin J; Kerse, Ngaire; Wilkinson, Tim; Menzies, Oliver; Rolleston, Anna; Chong, Yih Harng; Broad, Joanna B; Moyes, Simon A; Jatrana, Santosh; Teh, Ruth.
Afiliación
  • Connolly MJ; Freemasons' Department of Geriatric Medicine, University of Auckland, Auckland, New Zealand.
  • Kerse N; School of Population Health, University of Auckland, Auckland, New Zealand.
  • Wilkinson T; Department of Medicine, University of Otago, Christchurch, New Zealand.
  • Menzies O; Geriatric Medicine, Auckland District Health Board, Auckland, New Zealand.
  • Rolleston A; School of Population Health, University of Auckland, Auckland, New Zealand.
  • Chong YH; Department of Medicine, University of Otago, Christchurch, New Zealand.
  • Broad JB; Freemasons' Department of Geriatric Medicine, University of Auckland, Auckland, New Zealand.
  • Moyes SA; School of Population Health, University of Auckland, Auckland, New Zealand.
  • Jatrana S; Centre for Social Impact, Faculty of Business and Law, Swinburne University of Technology, Melbourne, Australia.
  • Teh R; University of Otago, Wellington, New Zealand.
BMJ Open ; 7(11): e016572, 2017 Nov 12.
Article en En | MEDLINE | ID: mdl-29133315
ABSTRACT

OBJECTIVES:

Serum testosterone (T) levels in men decline with age. Low T levels are associated with sarcopenia and frailty in men aged >80 years. T levels have not previously been directly associated with disability in older men. We explored associations between T levels, frailty and disability in a cohort of octogenarian men.

SETTING:

Data from all men from Life and Living in Advanced Age Cohort Study in New Zealand, a longitudinal cohort study in community-dwelling older adults.

PARTICIPANTS:

Community-dwelling (>80 years) adult men excluding those receiving T treatment or with prostatic carcinoma. OUTCOMES

MEASURES:

Associations between baseline total testosterone (TT) and calculated free testosterone (fT), frailty (Fried scale) and disability (Nottingham Extended Activities of Daily Living scale (NEADL)) (baseline and 24 months) were examined using multivariate regression and Wald's χ2 techniques. Subjects with the lowest quartile of baseline TT and fT values were compared with those in the upper three quartiles.

RESULTS:

Participants:

243 men, mean (SD) age 83.7 (2.0) years. Mean (SD) TT=17.6 (6.8) nmol/L and fT=225.3 (85.4) pmol/L. On multivariate analyses, lower TT levels were associated with frailty ß=0.41, p=0.017, coefficient of determination (R2)=0.10 and disability (NEADL) (ß=-1.27, p=0.017, R2=0.11), low haemoglobin (ß=-7.38, p=0.0016, R2=0.05), high fasting glucose (ß=0.38, p=0.038, R2=0.04) and high C reactive protein (CRP) (ß=3.57, p=0.01, R2=0.06). Low fT levels were associated with frailty (ß=0.39, p=0.024, R2=0.09) but not baseline NEADL (ß=-1.29, p=0.09, R2=0.09). Low fT was associated with low haemoglobin (ß=-7.83, p=0.0008, R2=0.05) and high CRP (ß=2.86, p=0.04, R2=0.05). Relationships between baseline TT and fT, and 24-month outcomes of disability and frailty were not significant.

CONCLUSIONS:

In men over 80 years, we confirm an association between T levels and baseline frailty scores. The new finding of association between T levels and disability is potentially relevant to debates on T supplementation in older men, though, as associations were not present at 24 months, further work is needed.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Testosterona / Sarcopenia / Fragilidad Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies País/Región como asunto: Oceania Idioma: En Revista: BMJ Open Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Testosterona / Sarcopenia / Fragilidad Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies País/Región como asunto: Oceania Idioma: En Revista: BMJ Open Año: 2017 Tipo del documento: Article